Reactions Weekly

, Volume 1658, Issue 1, pp 381–381 | Cite as

Pertuzumab/trastuzumab

Decreased left ventricular ejection fraction: case report
Case report
  • 27 Downloads

Reference

  1. Ajgal Z, et al. Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 21: 114-118, No. 2, Apr 2017. Available from: URL: http://doi.org/10.1016/j.canrad.2016.10.002 - FranceCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations